Global Autoimmune Disorders Treatment Market Research Report 2023

Report ID: 1983002 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Autoimmune Disorders Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Bridge Therapy
        1.2.3 Recombinant Technology
        1.2.4 Fecal Bacteriotherapy
        1.2.5 Hematopoietic Stem-cell Transplantation
        1.2.6 Phototherapy
        1.2.7 Helminthic Therapy
        1.2.8 Activation-induced Assays
    1.3 Market by Application
        1.3.1 Global Autoimmune Disorders Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Systemic Autoimmune Diseases
        1.3.3 Localized Autoimmune Diseases
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Autoimmune Disorders Treatment Market Perspective (2017-2028)
    2.2 Autoimmune Disorders Treatment Growth Trends by Region
        2.2.1 Autoimmune Disorders Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Autoimmune Disorders Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Autoimmune Disorders Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Autoimmune Disorders Treatment Market Dynamics
        2.3.1 Autoimmune Disorders Treatment Industry Trends
        2.3.2 Autoimmune Disorders Treatment Market Drivers
        2.3.3 Autoimmune Disorders Treatment Market Challenges
        2.3.4 Autoimmune Disorders Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Autoimmune Disorders Treatment Players by Revenue
        3.1.1 Global Top Autoimmune Disorders Treatment Players by Revenue (2017-2022)
        3.1.2 Global Autoimmune Disorders Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Autoimmune Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Autoimmune Disorders Treatment Revenue
    3.4 Global Autoimmune Disorders Treatment Market Concentration Ratio
        3.4.1 Global Autoimmune Disorders Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disorders Treatment Revenue in 2021
    3.5 Autoimmune Disorders Treatment Key Players Head office and Area Served
    3.6 Key Players Autoimmune Disorders Treatment Product Solution and Service
    3.7 Date of Enter into Autoimmune Disorders Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Disorders Treatment Breakdown Data by Type
    4.1 Global Autoimmune Disorders Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Autoimmune Disorders Treatment Forecasted Market Size by Type (2023-2028)
5 Autoimmune Disorders Treatment Breakdown Data by Application
    5.1 Global Autoimmune Disorders Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Autoimmune Disorders Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Autoimmune Disorders Treatment Market Size (2017-2028)
    6.2 North America Autoimmune Disorders Treatment Market Size by Country (2017-2022)
    6.3 North America Autoimmune Disorders Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Autoimmune Disorders Treatment Market Size (2017-2028)
    7.2 Europe Autoimmune Disorders Treatment Market Size by Country (2017-2022)
    7.3 Europe Autoimmune Disorders Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Autoimmune Disorders Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Autoimmune Disorders Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Autoimmune Disorders Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Autoimmune Disorders Treatment Market Size (2017-2028)
    9.2 Latin America Autoimmune Disorders Treatment Market Size by Country (2017-2022)
    9.3 Latin America Autoimmune Disorders Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Autoimmune Disorders Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Autoimmune Disorders Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Autoimmune Disorders Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Detail
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Autoimmune Disorders Treatment Introduction
        11.1.4 Abbott Laboratories Revenue in Autoimmune Disorders Treatment Business (2017-2022)
        11.1.5 Abbott Laboratories Recent Development
    11.2 Roche Diagnostics
        11.2.1 Roche Diagnostics Company Detail
        11.2.2 Roche Diagnostics Business Overview
        11.2.3 Roche Diagnostics Autoimmune Disorders Treatment Introduction
        11.2.4 Roche Diagnostics Revenue in Autoimmune Disorders Treatment Business (2017-2022)
        11.2.5 Roche Diagnostics Recent Development
    11.3 Siemens Healthcare
        11.3.1 Siemens Healthcare Company Detail
        11.3.2 Siemens Healthcare Business Overview
        11.3.3 Siemens Healthcare Autoimmune Disorders Treatment Introduction
        11.3.4 Siemens Healthcare Revenue in Autoimmune Disorders Treatment Business (2017-2022)
        11.3.5 Siemens Healthcare Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Detail
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Autoimmune Disorders Treatment Introduction
        11.4.4 Johnson & Johnson Revenue in Autoimmune Disorders Treatment Business (2017-2022)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Detail
        11.5.2 Boehringer Ingelheim Business Overview
        11.5.3 Boehringer Ingelheim Autoimmune Disorders Treatment Introduction
        11.5.4 Boehringer Ingelheim Revenue in Autoimmune Disorders Treatment Business (2017-2022)
        11.5.5 Boehringer Ingelheim Recent Development
    11.6 GlaxoSmithKline
        11.6.1 GlaxoSmithKline Company Detail
        11.6.2 GlaxoSmithKline Business Overview
        11.6.3 GlaxoSmithKline Autoimmune Disorders Treatment Introduction
        11.6.4 GlaxoSmithKline Revenue in Autoimmune Disorders Treatment Business (2017-2022)
        11.6.5 GlaxoSmithKline Recent Development
    11.7 AstraZeneca
        11.7.1 AstraZeneca Company Detail
        11.7.2 AstraZeneca Business Overview
        11.7.3 AstraZeneca Autoimmune Disorders Treatment Introduction
        11.7.4 AstraZeneca Revenue in Autoimmune Disorders Treatment Business (2017-2022)
        11.7.5 AstraZeneca Recent Development
    11.8 Sanofi
        11.8.1 Sanofi Company Detail
        11.8.2 Sanofi Business Overview
        11.8.3 Sanofi Autoimmune Disorders Treatment Introduction
        11.8.4 Sanofi Revenue in Autoimmune Disorders Treatment Business (2017-2022)
        11.8.5 Sanofi Recent Development
    11.9 Merck
        11.9.1 Merck Company Detail
        11.9.2 Merck Business Overview
        11.9.3 Merck Autoimmune Disorders Treatment Introduction
        11.9.4 Merck Revenue in Autoimmune Disorders Treatment Business (2017-2022)
        11.9.5 Merck Recent Development
    11.10 Pfizer
        11.10.1 Pfizer Company Detail
        11.10.2 Pfizer Business Overview
        11.10.3 Pfizer Autoimmune Disorders Treatment Introduction
        11.10.4 Pfizer Revenue in Autoimmune Disorders Treatment Business (2017-2022)
        11.10.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Autoimmune Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Bridge Therapy
    Table 3. Key Players of Recombinant Technology
    Table 4. Key Players of Fecal Bacteriotherapy
    Table 5. Key Players of Hematopoietic Stem-cell Transplantation
    Table 6. Key Players of Phototherapy
    Table 7. Key Players of Helminthic Therapy
    Table 8. Key Players of Activation-induced Assays
    Table 9. Global Autoimmune Disorders Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Autoimmune Disorders Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Autoimmune Disorders Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Autoimmune Disorders Treatment Market Share by Region (2017-2022)
    Table 13. Global Autoimmune Disorders Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Autoimmune Disorders Treatment Market Share by Region (2023-2028)
    Table 15. Autoimmune Disorders Treatment Market Trends
    Table 16. Autoimmune Disorders Treatment Market Drivers
    Table 17. Autoimmune Disorders Treatment Market Challenges
    Table 18. Autoimmune Disorders Treatment Market Restraints
    Table 19. Global Autoimmune Disorders Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Autoimmune Disorders Treatment Market Share by Players (2017-2022)
    Table 21. Global Top Autoimmune Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disorders Treatment as of 2021)
    Table 22. Ranking of Global Top Autoimmune Disorders Treatment Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Autoimmune Disorders Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Autoimmune Disorders Treatment Product Solution and Service
    Table 26. Date of Enter into Autoimmune Disorders Treatment Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Autoimmune Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Autoimmune Disorders Treatment Revenue Market Share by Type (2017-2022)
    Table 30. Global Autoimmune Disorders Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Autoimmune Disorders Treatment Revenue Market Share by Type (2023-2028)
    Table 32. Global Autoimmune Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Autoimmune Disorders Treatment Revenue Market Share by Application (2017-2022)
    Table 34. Global Autoimmune Disorders Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Autoimmune Disorders Treatment Revenue Market Share by Application (2023-2028)
    Table 36. North America Autoimmune Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Autoimmune Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Autoimmune Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Europe Autoimmune Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Asia-Pacific Autoimmune Disorders Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 41. Asia-Pacific Autoimmune Disorders Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 42. Latin America Autoimmune Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Latin America Autoimmune Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Middle East & Africa Autoimmune Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Middle East & Africa Autoimmune Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Abbott Laboratories Company Detail
    Table 47. Abbott Laboratories Business Overview
    Table 48. Abbott Laboratories Autoimmune Disorders Treatment Product
    Table 49. Abbott Laboratories Revenue in Autoimmune Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 50. Abbott Laboratories Recent Development
    Table 51. Roche Diagnostics Company Detail
    Table 52. Roche Diagnostics Business Overview
    Table 53. Roche Diagnostics Autoimmune Disorders Treatment Product
    Table 54. Roche Diagnostics Revenue in Autoimmune Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 55. Roche Diagnostics Recent Development
    Table 56. Siemens Healthcare Company Detail
    Table 57. Siemens Healthcare Business Overview
    Table 58. Siemens Healthcare Autoimmune Disorders Treatment Product
    Table 59. Siemens Healthcare Revenue in Autoimmune Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 60. Siemens Healthcare Recent Development
    Table 61. Johnson & Johnson Company Detail
    Table 62. Johnson & Johnson Business Overview
    Table 63. Johnson & Johnson Autoimmune Disorders Treatment Product
    Table 64. Johnson & Johnson Revenue in Autoimmune Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 65. Johnson & Johnson Recent Development
    Table 66. Boehringer Ingelheim Company Detail
    Table 67. Boehringer Ingelheim Business Overview
    Table 68. Boehringer Ingelheim Autoimmune Disorders Treatment Product
    Table 69. Boehringer Ingelheim Revenue in Autoimmune Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 70. Boehringer Ingelheim Recent Development
    Table 71. GlaxoSmithKline Company Detail
    Table 72. GlaxoSmithKline Business Overview
    Table 73. GlaxoSmithKline Autoimmune Disorders Treatment Product
    Table 74. GlaxoSmithKline Revenue in Autoimmune Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 75. GlaxoSmithKline Recent Development
    Table 76. AstraZeneca Company Detail
    Table 77. AstraZeneca Business Overview
    Table 78. AstraZeneca Autoimmune Disorders Treatment Product
    Table 79. AstraZeneca Revenue in Autoimmune Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 80. AstraZeneca Recent Development
    Table 81. Sanofi Company Detail
    Table 82. Sanofi Business Overview
    Table 83. Sanofi Autoimmune Disorders Treatment Product
    Table 84. Sanofi Revenue in Autoimmune Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 85. Sanofi Recent Development
    Table 86. Merck Company Detail
    Table 87. Merck Business Overview
    Table 88. Merck Autoimmune Disorders Treatment Product
    Table 89. Merck Revenue in Autoimmune Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 90. Merck Recent Development
    Table 91. Pfizer Company Detail
    Table 92. Pfizer Business Overview
    Table 93. Pfizer Autoimmune Disorders Treatment Product
    Table 94. Pfizer Revenue in Autoimmune Disorders Treatment Business (2017-2022) & (US$ Million)
    Table 95. Pfizer Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Autoimmune Disorders Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Bridge Therapy Features
    Figure 3. Recombinant Technology Features
    Figure 4. Fecal Bacteriotherapy Features
    Figure 5. Hematopoietic Stem-cell Transplantation Features
    Figure 6. Phototherapy Features
    Figure 7. Helminthic Therapy Features
    Figure 8. Activation-induced Assays Features
    Figure 9. Global Autoimmune Disorders Treatment Market Share by Application in 2021 & 2028
    Figure 10. Systemic Autoimmune Diseases Case Studies
    Figure 11. Localized Autoimmune Diseases Case Studies
    Figure 12. Autoimmune Disorders Treatment Report Years Considered
    Figure 13. Global Autoimmune Disorders Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Autoimmune Disorders Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Autoimmune Disorders Treatment Market Share by Region: 2021 VS 2028
    Figure 16. Global Autoimmune Disorders Treatment Market Share by Players in 2021
    Figure 17. Global Top Autoimmune Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disorders Treatment as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Autoimmune Disorders Treatment Revenue in 2021
    Figure 19. North America Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America Autoimmune Disorders Treatment Market Share by Country (2017-2028)
    Figure 21. United States Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Autoimmune Disorders Treatment Market Share by Country (2017-2028)
    Figure 25. Germany Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Autoimmune Disorders Treatment Market Share by Region (2017-2028)
    Figure 33. China Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Autoimmune Disorders Treatment Market Share by Country (2017-2028)
    Figure 41. Mexico Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Autoimmune Disorders Treatment Market Share by Country (2017-2028)
    Figure 45. Turkey Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia Autoimmune Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Abbott Laboratories Revenue Growth Rate in Autoimmune Disorders Treatment Business (2017-2022)
    Figure 48. Roche Diagnostics Revenue Growth Rate in Autoimmune Disorders Treatment Business (2017-2022)
    Figure 49. Siemens Healthcare Revenue Growth Rate in Autoimmune Disorders Treatment Business (2017-2022)
    Figure 50. Johnson & Johnson Revenue Growth Rate in Autoimmune Disorders Treatment Business (2017-2022)
    Figure 51. Boehringer Ingelheim Revenue Growth Rate in Autoimmune Disorders Treatment Business (2017-2022)
    Figure 52. GlaxoSmithKline Revenue Growth Rate in Autoimmune Disorders Treatment Business (2017-2022)
    Figure 53. AstraZeneca Revenue Growth Rate in Autoimmune Disorders Treatment Business (2017-2022)
    Figure 54. Sanofi Revenue Growth Rate in Autoimmune Disorders Treatment Business (2017-2022)
    Figure 55. Merck Revenue Growth Rate in Autoimmune Disorders Treatment Business (2017-2022)
    Figure 56. Pfizer Revenue Growth Rate in Autoimmune Disorders Treatment Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Roche Diagnostics
Siemens Healthcare
Johnson & Johnson
Boehringer Ingelheim
GlaxoSmithKline
AstraZeneca
Sanofi
Merck
Pfizer
Frequently Asked Questions
Autoimmune Disorders Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Autoimmune Disorders Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Autoimmune Disorders Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Autoinjectors

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Automated Retail

Automated Retail market is segmented by players, region (country), by Type and by Application. Pl ... Read More